These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction. Fujiwara T; Grimm EA J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells. Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071 [TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells. Dullens HF; Wind JC; Maas RA; Bernsen MR; Vulto IM; Rademakers LH; Den Otter W Int Immunol; 1991 Oct; 3(10):959-64. PubMed ID: 1756146 [TBL] [Abstract][Full Text] [Related]
7. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro. Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343 [TBL] [Abstract][Full Text] [Related]
8. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy. Streck RJ; Helinski EH; Ovak GM; Pauly JL J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448 [TBL] [Abstract][Full Text] [Related]
9. Morphologic analysis of human lymphokine-activated killer (LAK) cells. Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor. Teichmann JV; Ludwig WD; Thiel E Leuk Res; 1992; 16(3):287-98. PubMed ID: 1560676 [TBL] [Abstract][Full Text] [Related]
11. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture. Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410 [TBL] [Abstract][Full Text] [Related]
12. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis. Basu S; Sodhi A Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394 [TBL] [Abstract][Full Text] [Related]
13. Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity. Carr ME; Sajer SA; Spaulding A J Lab Clin Med; 1992 Feb; 119(2):132-8. PubMed ID: 1740625 [TBL] [Abstract][Full Text] [Related]
14. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model]. Iwasaki K Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768 [TBL] [Abstract][Full Text] [Related]